Tag - older adults

GHP News Latest Science

Literature update ViVa week 16-2026

1. MF59-aQIV looks economically persuasive in Korea and Taiwan — but the price assumptions do a lot of the work This modelling study assessed the cost-effectiveness of MF59-adjuvanted quadrivalent influenza vaccine...

22 April, 2026

23 min read

GHP News Latest Science

RSV prefusion F vaccine for prevention of hospitalization in older adults

The DAN-RSV phase 4 pragmatic randomized trial evaluated the effectiveness and safety of the bivalent RSV prefusion F protein–based vaccine (RSVpreF) in adults aged 60 years and older during the 2024–2025 season in...

9 September, 2025

2 min read

GHP News Latest Science

The economic and clinical impact of RSV in older adults

Respiratory syncytial virus (RSV) poses a significant health risk to individuals aged 60 years and older, often leading to severe acute respiratory infections (ARIs) that result in hospitalizations and substantial...

3 March, 2025

4 min read